Question to the Department for Transport:

To ask His Majesty's Government what assessment they have made of the total cost of injuries caused by e-bikes and e-scooters in each of the past three years for which figures are available.

Answered by Lord Hendy of Richmond Hill - Minister of State (Department for Transport)

Statistics on road collisions and casualties are published on the government site which include data on the overall cost of prevention of road casualties and collisions. However, the published figures do not provide a breakdown of the costs attributable to a particular vehicle type.

Question to the Department of Health and Social Care:

To ask His Majesty's Government what is the pathway to treatment for a patient diagnosed with osteoporosis.

Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)

We would expect healthcare professionals to follow the National Institute for Health and Care Excellence (NICE) clinical knowledge summary on osteoporosis and the prevention of fragility fractures. The clinical knowledge summary outlines the steps that healthcare professionals should take in the assessment and management of osteoporosis.

A diagnosis of osteoporosis is made following clinical assessment and in some cases by use of blood tests and DEXA scans. The National Health Service does not provide universal osteoporosis screening, instead, a targeted approach is used to identify those most likely to benefit from assessment and treatment. Tools like FRAX are recommended to calculate 10-year fracture risk and guide clinical decisions. A DEXA scan can also be used to measure bone mineral density.

There are a number of NICE recommended treatments for osteoporosis. Since 2022, two new drugs have been recommended by NICE for the treatment of osteoporosis in post-menopausal women, abaloparatide and romosozumab. These medications help to strengthen the bones and prevent bone loss, reducing the risk of fractures.

Question to the Department of Health and Social Care:

To ask His Majesty's Government whether they conducted a health impact equality assessment before awarding the Meningitis B vaccination programme to community pharmacies.

Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)

In developing vaccination policy, the Department has due regard to its duties under the Public Sector Equality Duty. Consideration of equality and health inequalities impacts are undertaken as part of the development, implementation, and review of vaccination programmes. In developing the policy on this urgent meningococcal B (MenB) vaccination programme, the Department had due regard to its duties under the Public Sector Equality Duty.

The operational delivery of vaccinations is led by NHS England, including the providers commissioned to deliver the vaccination programme. An Equality Health Impact Assessment is being developed by NHS England to support in the identification and mitigation of inequalities in access and outcomes as relates to the rollout of this MenB programme.

Question to the Department of Health and Social Care:

To ask His Majesty's Government how they intend to maximise the uptake of Meningitis B vaccinations among university students living in rural areas ahead of the start of the academic year.

Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)

Getting two doses of the meningitis B vaccine before the autumn term is one of the most important things young people can do to protect themselves from meningitis B disease.

The UK Health Security Agency has produced a wide range of materials to inform young people of the offer and to support informed consent. We are working closely with cross-Government colleagues and partners, including those in the university and further education sectors, and with stakeholders to ensure that information on eligibility and access to vaccination in each of the four nations is available to all eligible young people, including those living in rural areas, ahead of the autumn term. Information will be shared via direct communications, social media platforms, and other routes.

NHS England will continually monitor community pharmacy sign up and will work with regional teams to consider supplementary offers where geographical gaps are identified.

Question to the Department of Health and Social Care:

To ask His Majesty's Government who they intend to administer Meningitis B vaccines in rural areas where no community pharmacies exist.

Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)

Vaccinations will primarily be offered in community pharmacies, providing flexibility for the mobile student population who may move to a new area between doses.

To support access in all areas, NHS England regional teams will also be supported to commission appropriate supplementary providers in their area where needed to ensure that everyone who is eligible can get vaccinated.

The first dose will be available until 31 December 2026 and the second dose until 31 March 2027. The appointment window remains open beyond summer to allow for as many of those eligible as possible to get vaccinated, but the strong recommendation is to have the vaccine in July and August.

Question to the Ministry of Housing, Communities and Local Government:

To ask His Majesty's Government what assessment they have made of the insurability of homes built on floodplains since 2009.

Answered by Baroness Taylor of Stevenage - Parliamentary Under-Secretary (Housing, Communities and Local Government)

The availability of insurance is determined on a case-by-case basis by insurers, but the Government engages with the industry on a regular basis through the Flood Resilience Taskforce.

Between 16 December 2025 and 10 March 2026, we consulted on a new NPPF, including proposals in a new standalone chapter dedicated to managing flood risk and coastal change. We are currently analysing the feedback received and will publish our response in due course.

Question to the Department for Energy Security & Net Zero:

To ask His Majesty's Government what assessment they have made of the compatibility of their clean energy plans with protection of nature and the environment, in light of their reported (1) environmental impacts, and (2) flammability and combustibility risks.

Answered by Baroness Curran - Parliamentary Under-Secretary of State (Department for Energy Security and Net Zero)

The Government believes that the accelerated rollout of clean energy generation is compatible with protection of the natural environment.

All energy proposals are subject to a rigorous planning process, in which the views and interests of local communities are considered. This includes any impact on biodiversity, the environment, and fire risk.

Project developers typically must complete an Environmental Statement (ES) as part of any application. The ES requires developers to consider all potential impacts throughout a project’s life from pre-development to construction, operation, and decommissioning.

Found: Apologies and notices Apologies were received from Baroness McIntosh of Pickering and Baroness Rafferty

This inquiry will consider how the UK can maintain a secure, affordable and low-carbon electricity supply during ‘dunkelflaute’ events – periods of low wind and solar energy generation. This will include an assessment of current UK preparedness for dunkelflaute conditions, future plans, and policy and regulatory gaps.